NDC 73190-052 – Deferasirox
Deferasirox 360 mg/1 · Tablet · Oral
Product NDC73190-052
Product details
- Brand name
- Deferasirox
- Generic name
- Deferasirox
- Labeler
- AvKARE
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA210945
- Marketed since
- January 14, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferasirox 360 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73190-052-30 | 30 TABLET in 1 BOTTLE (73190-052-30) | Jan 14, 2026 |
Other Deferasirox products
- 45963-455 Deferasirox 250 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 45963-456 Deferasirox 500 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 62332-326 Deferasirox 500 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-411 Deferasirox 180 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-410 Deferasirox 90 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-324 Deferasirox 125 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-325 Deferasirox 250 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-412 Deferasirox 360 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 46708-326 Deferasirox 500 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Limited
- 46708-325 Deferasirox 250 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Limited
- 46708-411 Deferasirox 180 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-410 Deferasirox 90 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited